News
-
-
PRESS RELEASE
2025 Full Year Results Announcement
Gulf Keystone Petroleum Ltd announces 2025 Full Year Results, achieving strong operational and financial performance, operating in Kurdistan. CEO highlights operational deliveries, increased production, and growth projects. Suspends 2026 guidance due to regional conflicts -
-
-
-
-
PRESS RELEASE
Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression -
-
PRESS RELEASE
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Evotec receives $10 M milestone from Bristol Myers Squibb for Phase 1 clinical study initiation of BMS-986506 in clear cell renal cell carcinoma. Collaboration focuses on protein degradation for cancer treatment -
